TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference

GlobeNewswire Inc. Logo GlobeNewswire Inc. • •By Castle Biosciences Inc.
Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference

Castle Biosciences announced its Q3 2025 financial results and launched AdvanceAD-Tx, a genetic expression test to help guide systemic treatment decisions for patients with moderate-to-severe atopic dermatitis aged 12 and older.

Insights
BCS   neutral

Mentioned as one of the sales agents and forward purchasers, playing a standard financial intermediary role


CSTL   positive

Company is expanding its diagnostic test portfolio with a new targeted solution for atopic dermatitis treatment, demonstrating ongoing innovation and market expansion